📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Switching to biosimilar infliximab: real world data in patients with severe inflammatory arthritis. (2018)

First Author: Holroyd CR

Attributed to: Sarcopenia, Frailty and Clinical Practice in Older People funded by MRC

Abstract

No abstract provided

Bibliographic Information

PubMed Identifier: 29352847

Publication URI: http://europepmc.org/abstract/MED/29352847

Type: Journal Article/Review

Volume: 36

Parent Publication: Clinical and experimental rheumatology

Issue: 1

ISSN: 0392-856X